Aviva B Sopher1, Ilene Fennoy, Sharon E Oberfield. 1. Division of Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: To update the reader's knowledge about the factors that influence bone mineral accrual and to review the advances in the assessment of bone health and treatment of bone disorders. RECENT FINDINGS: Maternal vitamin D status influences neonatal calcium levels, bone mineral density (BMD) and bone size. In turn, BMD z-score tends to track in childhood. These factors highlight the importance of bone health as early as fetal life. Dual-energy x-ray absorptiometry is the mainstay of clinical bone health assessment in this population because of the availability of appropriate reference data. Recently, more information has become available about the assessment and treatment of bone disease in chronically ill pediatric patients. SUMMARY: Bone health must become a health focus starting prenatally in order to maximize peak bone mass and to prevent osteoporosis-related bone disease in adulthood. Vitamin D, calcium and weight-bearing activity are the factors of key importance throughout childhood in achieving optimal bone health as BMD z-score tracks through childhood and into adulthood. Recent updates of the International Society for Clinical Densitometry focus on the appropriate use of dual-energy x-ray absorptiometry in children of all ages, including children with chronic disease, and on the treatment of pediatric bone disease.
PURPOSE OF REVIEW: To update the reader's knowledge about the factors that influence bone mineral accrual and to review the advances in the assessment of bone health and treatment of bone disorders. RECENT FINDINGS: Maternal vitamin D status influences neonatal calcium levels, bone mineral density (BMD) and bone size. In turn, BMD z-score tends to track in childhood. These factors highlight the importance of bone health as early as fetal life. Dual-energy x-ray absorptiometry is the mainstay of clinical bone health assessment in this population because of the availability of appropriate reference data. Recently, more information has become available about the assessment and treatment of bone disease in chronically ill pediatric patients. SUMMARY: Bone health must become a health focus starting prenatally in order to maximize peak bone mass and to prevent osteoporosis-related bone disease in adulthood. Vitamin D, calcium and weight-bearing activity are the factors of key importance throughout childhood in achieving optimal bone health as BMD z-score tracks through childhood and into adulthood. Recent updates of the International Society for Clinical Densitometry focus on the appropriate use of dual-energy x-ray absorptiometry in children of all ages, including children with chronic disease, and on the treatment of pediatric bone disease.
Authors: L M Ward; F Rauch; M P Whyte; J D'Astous; P E Gates; D Grogan; E L Lester; R E McCall; T A Pressly; J O Sanders; P A Smith; R D Steiner; E Sullivan; G Tyerman; D L Smith-Wright; N Verbruggen; N Heyden; A Lombardi; F H Glorieux Journal: J Clin Endocrinol Metab Date: 2010-11-24 Impact factor: 5.958
Authors: Anne C Looker; Clifford L Johnson; David A Lacher; Christine M Pfeiffer; Rosemary L Schleicher; Christopher T Sempos Journal: NCHS Data Brief Date: 2011-03
Authors: Marcella D Walker; X Sherry Liu; Emily Stein; Bin Zhou; Ervis Bezati; Donald J McMahon; Julia Udesky; George Liu; Elizabeth Shane; X Edward Guo; John P Bilezikian Journal: J Bone Miner Res Date: 2011-07 Impact factor: 6.741
Authors: H T Viljakainen; E Saarnio; T Hytinantti; M Miettinen; H Surcel; O Mäkitie; S Andersson; K Laitinen; C Lamberg-Allardt Journal: J Clin Endocrinol Metab Date: 2010-02-05 Impact factor: 5.958
Authors: A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses Journal: J Clin Endocrinol Metab Date: 2010-11-29 Impact factor: 5.958
Authors: H T Viljakainen; T Korhonen; T Hytinantti; E K A Laitinen; S Andersson; O Mäkitie; C Lamberg-Allardt Journal: Osteoporos Int Date: 2010-12-10 Impact factor: 4.507
Authors: Babette S Zemel; Virginia A Stallings; Mary B Leonard; Donna R Paulhamus; Heidi H Kecskemethy; H Theodore Harcke; Richard C Henderson Journal: J Clin Densitom Date: 2009-03-24 Impact factor: 2.617
Authors: Seung Hyun Yoo; Jung Ah Lee; Seo Young Kang; Young Sik Kim; Sung Sunwoo; Beom Soo Kim; Jeong-Hwan Yook Journal: Gastric Cancer Date: 2017-11-21 Impact factor: 7.370
Authors: Ketil Størdal; Karl Mårild; German Tapia; Margareta Haugen; Arieh S Cohen; Benedicte A Lie; Lars C Stene Journal: J Clin Endocrinol Metab Date: 2017-11-01 Impact factor: 5.958